Trials / Completed
CompletedNCT05141110
Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects
A Phase 1 Clinical Trial, Open-label, Randomized Study in Healthy Subjects to Evaluate Pharmacokinetic Characteristics and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics and safety of NVP-1705 and NVP-1705-R.
Detailed description
Evaluate the pharmacokinetics and safety of NVP-1705 compared to NVP-1705-R
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1705 | NVP-1705 |
| DRUG | NVP-1705-R | NVP-1705-R |
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2022-04-27
- Completion
- 2022-06-29
- First posted
- 2021-12-02
- Last updated
- 2022-09-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05141110. Inclusion in this directory is not an endorsement.